The Myelodysplastic Syndromes Channel on VJHemOnc is an independent medical education platform, supported with funding from Geron (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MDS 2020 | Luspatercept for MDS-associated anemia
Alan List
• 5 Mar 2020
Alan List, MD, Tampa, FL, discusses the drug luspatercept, which has been shown to be effective for the treatment of myelodysplastic syndrome (MDS)-associated anemia. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.
